tradingkey.logo
tradingkey.logo
Suchen

BioNexus Gene Lab Corp

BGLC
Zur Watchlist hinzufügen
2.030USD
+0.020+0.99%
Handelsschluss 07/02, 13:00ETKurse um 15 Minuten verzögert
4.91MMarktkapitalisierung
VerlustKGV TTM

mehr Informationen über BioNexus Gene Lab Corp Unternehmen

BioNexus Gene Lab Corp. is a biotechnology company specializing in precision diagnostics and specialty chemical solutions. The Company, through its wholly owned subsidiary Chemrex Corporation Sdn. Bhd., focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its segments include Trading of industrial chemicals, Provision for genomic screening services, and Investment holding. The Provision for genomic screening services segment includes commercializing proprietary blood-based diagnostic test for early disease detection. Its subsidiary MRNA Scientific Sdn. Bhd owns algorithm software, technology, and know-how related to the detection of common diseases through blood analysis which it uses in its business.

BioNexus Gene Lab Corp Informationen

BörsenkürzelBGLC
Name des UnternehmensBioNexus Gene Lab Corp
IPO-datumMar 11, 2020
CEOTan (Lee Su-Leng)
Anzahl der mitarbeiter30
WertpapierartOrdinary Share
GeschäftsjahresendeMar 11
Addresse10-2 Tower B, Vertical Business Suite
StadtKUALA LUMPUR
BörseNASDAQ OMX - NASDAQ BASIC
LandMalaysia
Postleitzahl59200
Telefon13072416898
Websitehttps://www.bionexusgenelab.com/
BörsenkürzelBGLC
IPO-datumMar 11, 2020
CEOTan (Lee Su-Leng)

Führungskräfte von BioNexus Gene Lab Corp

Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Jook Yuen Low
Ms. Jook Yuen Low
Independent Director
Independent Director
1.26K
--
Mr. Chi Yuen (George) Leong
Mr. Chi Yuen (George) Leong
Director
Director
--
--
Mr. Teng Fook Fong
Mr. Teng Fook Fong
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Chee Keong Yap
Mr. Chee Keong Yap
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Lee Su-Leng Tan
Mr. Lee Su-Leng Tan
President, Chief Executive Officer, Chief Operating Officer
President, Chief Executive Officer, Chief Operating Officer
--
--
Mr. Min Fong Yeat
Mr. Min Fong Yeat
Chairman of the Board
Chairman of the Board
--
--
Ms. Meng Wong Yee
Ms. Meng Wong Yee
Director
Director
--
--
Ms. Hua Yew Chak
Ms. Hua Yew Chak
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Teong Teoh Boon
Mr. Teong Teoh Boon
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Ping Lin Chai
Mr. Ping Lin Chai
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Jook Yuen Low
Ms. Jook Yuen Low
Independent Director
Independent Director
1.26K
--
Mr. Chi Yuen (George) Leong
Mr. Chi Yuen (George) Leong
Director
Director
--
--
Mr. Teng Fook Fong
Mr. Teng Fook Fong
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Chee Keong Yap
Mr. Chee Keong Yap
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Lee Su-Leng Tan
Mr. Lee Su-Leng Tan
President, Chief Executive Officer, Chief Operating Officer
President, Chief Executive Officer, Chief Operating Officer
--
--
Mr. Min Fong Yeat
Mr. Min Fong Yeat
Chairman of the Board
Chairman of the Board
--
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von BioNexus Gene Lab Corp?

Die fünf größten Anteilseigner von BioNexus Gene Lab Corp sind: Ms. Jook Yuen Low

Wie viele Institutionen halten Anteile an BioNexus Gene Lab Corp (BGLC)?

Mit Stand vom 2026Q1 halten 13 Institutionen Anteile an BioNexus Gene Lab Corp, mit einem Gesamtmarktwert von etwa 50.43K, was 2.09% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um 10001.00 gestiegen.